These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30191970)

  • 21. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
    Ren K; Yu Y; Wang X; Liu H; Zhao J
    Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
    Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
    Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM201A knockdown inhibits proliferation and invasion of lung adenocarcinoma cells by regulating miR-7515/GLO1 axis.
    Huang J; Yu Q; Zhou Y; Chu Y; Jiang F; Wang Q
    J Cell Physiol; 2021 Aug; 236(8):5620-5632. PubMed ID: 33687075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    Cancer Med; 2018 Nov; 7(11):5554-5566. PubMed ID: 30280514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylated CD36 gene affected the progression of lung cancer.
    Sun Q; Zhang W; Wang L; Guo F; Song D; Zhang Q; Zhang D; Fan Y; Wang J
    Gene; 2018 Dec; 678():395-406. PubMed ID: 29969695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function of low ADARB1 expression in lung adenocarcinoma.
    Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
    PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
    Li H; Tong L; Tao H; Liu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.
    Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF
    Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
    Hu B; Zhu X; Lu J
    Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G protein gamma 7 suppresses progression of lung adenocarcinoma by inhibiting E2F transcription factor 1.
    Zheng H; Tian H; Yu X; Ren P; Yang Q
    Int J Biol Macromol; 2021 Jul; 182():858-865. PubMed ID: 33864871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.